Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qi-Zheng-Xiao-Tong Plaster is a Traditional Chinese Medicine (TCM) topical patch, specifically a Tibetan medicine formulation, used for the treatment of knee osteoarthritis, chronic pain, and musculoskeletal injuries. Its primary active botanical components include *Lamiophlomis rotata* and *Curcuma longa* (turmeric), which are formulated in a hydrophilic adhesive vehicle for transdermal delivery. The plaster exerts anti-inflammatory and analgesic effects, likely through the inhibition of pro-inflammatory cytokines and enzymes such as COX-2. It is widely marketed in China and has served as a standard-of-care active control in clinical trials for new topical osteoarthritis treatments.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on qizheng xiaotong plaster (奇正藏药).